Patented consumer healthcare innovation for a $12 billion global market
A fast-application condom technology designed for speed, hygiene and correct use, with patent protection across 108 countries.

by patents
international launch
Product demonstration
The technology in action
Two short videos introduce the project, demonstrate the packaging concept and show the applicator-based user journey.
UMITECH overview
Technology and investment overview
Product demonstration
A closer look at the application experience
Category challenge
A mature category where the user journey has remained unchanged for decades
Traditional condoms still create friction at the moment of use.
Slow application
Extra steps create friction at a critical point in the user journey.
Inconvenient packaging
Traditional foil packaging is not always quick or predictable to open.
Direct hand contact
Users must handle the latex directly during application.
Orientation errors
The correct orientation can be difficult to identify immediately, especially without visual confirmation.
An awkward pause
The category still requires users to stop and shift their attention.
Limited confidence
Low-light conditions and hygiene concerns increase uncertainty.

The UMITECH solution
UMITECH changes the application experience
The innovation is not only in the product, but in creating a shorter, clearer and more hygienic user journey.
Product mechanics
Three simple actions
The sequence reduces the number of decisions and streamlines the familiar application process.

Break open the package

Pull the sides apart

Apply and remove the applicator
The applicator is designed to minimise direct hand contact with the latex during application.
Intellectual property
Protected technology with global patent coverage
The patent portfolio provides a foundation for licensing, international scaling and strategic partnerships.
Patented technology
Fast application as a protected part of the user journey.
Internal applicator
The applicator is positioned inside the foil packaging.
Five-year shelf life
Target product shelf life according to project materials.
Applications in 108 countries
An international patent protection perimeter.
More than 50 patents
Already granted across key jurisdictions.
IP consolidation
Intended to be consolidated within UMITECH as part of the investment structure.

Business model
An asset-light, scalable FMCG model
UMITECH retains control of key intellectual and production assets while specialist partners execute operational functions.
UMITECH owns
- Trademark
- Patents
- Manufacturing equipment / line
- Product and marketing strategy
Manufacturing partner
- Contract manufacturing partner
- Production line built to UMITECH specifications
- Asset-light contract manufacturing model
Distributor
- Receives finished goods
- Supplies retail networks
- Manages local distribution and merchandising
Consumers and channels
- Pharmacies and convenience retail
- E-commerce and marketplaces
- Impulse purchase and repeat-sales potential
Market opportunity
A global category with recurring demand
A mature category, frequent repeat purchases and a broad range of channels create a foundation for a scalable FMCG product.
Go-to-market channels
The chart represents a qualitative assessment of the investment case rather than a statistical study.
Commercial readiness
Preparing for international launch
The corporate, manufacturing and distribution foundations are in place for the project's next phase.

Contract manufacturing with equipment built to UMITECH specifications
Company incorporated
Dubai, UAE
Corporate bank account
Opened for operating activities
Manufacturing partner
Identified for the contract model
Production-line model
Developed to project requirements
Initial launch in Thailand
Distribution preparations are under way
Next markets
Scaling priorities have been identified
Advantages
A differentiated application experience
Condoms are an established barrier-contraception category with a broad range of product formats. Most existing products differentiate through materials, texture, size or lubrication rather than changing the application experience itself.
The global category includes anatomical, flavoured, textured, ultra-thin, extra-strong, polyurethane, lubricated, size-specific and fast-application formats. Several indirect fast-application technologies are marketed under Sagami, Wingman and One Touch.
| Investor comparison | UMITECH | Wingman | One Touch | Sagami |
|---|---|---|---|---|
| Application in 2–3 seconds | ||||
| Ease of use | ||||
| Use in low-light conditions | ||||
| Minimised direct hand contact with latex |
Investor takeaway
The current competitive set does not present a strong mass-market direct alternative combining fast application, low-light usability and minimised direct hand contact with latex. UMITECH brings these advantages together in one protected user experience.
Investment opportunity
Investment round
Capital will fund the transition from a prepared project platform to manufacturing, certification and international market launch.
Round size
€5.1millionProposed equity
10%Use of funds
Risk management
Key risks and mitigation measures
Intellectual property risk
Transfer and consolidation of intellectual property at company level.
Manufacturing risk
A production schedule, service-level agreements and formalised quality guarantees.
Regulatory risk
A country-by-country registration and certification roadmap.
Sell-out risk
Pilot shipments, retail sell-out monitoring and repeat-order analysis.
Marketing risk
Trust built through pharmacy and healthcare channels, product demonstration and premium packaging.
Investor conversations
Let's discuss the UMITECH investment opportunity
Schedule a direct conversation about the technology, intellectual property, commercial roadmap and investment round.